Company: SXTPW
Filing Date: 2025-09-05
Form Type: 424B5
Source: 0001213900-25-085050
Chunk: 38

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-09-05
Form: 424B5
Chunk 38
---
 difference between the public offering price per share and the net tangible book value
per share of our common stock immediately after this offering.

The historical net tangible book value of our
common stock as of June 30, 2025 was $2,202,000, or $1.50 per share. Historical net tangible book value per share of our common stock
represents our total tangible assets (total assets less intangible assets) less total liabilities divided by the number of shares of common
stock outstanding as of that date. Dilution in net tangible book value per share represents the difference between the amount per share
paid by purchasers of shares of common stock in this offering and the net tangible book value per share of our common stock immediately
after this offering.

After giving effect to (i)
the receipt of $4,459,874 in net proceeds from our registered direct offering completed on July 16, 2025 (the “July 2025 Offering”),
pursuant to which we issued 1,753,314 shares of our common stock, 878,264 pre-funded warrants to purchase our common stock, 2,631,578
series A-1 warrants to purchase our common stock, and 2,631,578 series A-2 warrants to purchase our common stock, and (ii) the issuance
of 878,624 shares of our common stock upon the exercise of 878,264 pre-funded warrants issued in the July 2025 Offering, resulting in
incremental proceeds of $125 (net of $754 in proceeds from pre-funded warrants prepaid at the closing of the July 2025 Offering), after
June 30, 2025 but prior to the date of this prospectus supplement, our pro forma net tangible book value as of June 30, 2025 would have
been $6,661,999 or approximately $1.623 per share of our common stock.

After giving effect to the assumed issuance and
sale of shares of our common stock in this offering in the aggregate amount of $1,397,532 at an assumed public offering price of $1.46
per share, which was the last reported sale price of our common stock on The Nasdaq Capital Market on September 3, 2025, and after deducting
the commissions and estimated offering expenses payable by us, our pro forma as-adjusted net tangible book value as of June 30, 2025 would
have been $7,857,605 or approximately $1